Friday 6 November 2026
Export BAX’s income statement to Excel — free account
Baxter International Inc.
BAX Healthcare Medical Instruments & Supplies
Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024.
- Revenue
- +4.97%
- EPS
- +731.9%
- Free cash flow
- +255.6%
- Total debt
- −9.48%
Quarter to September 2026, against a year earlier
25.57
0.93
−3.51%
Follow BAX
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 3 | 4 |
+8 more TTM periods Free account |
| (10.56%) | (15.78%) | (16.80%) | (14.58%) | ||
| (3.57%) | (5.21%) | (5.34%) | (4.18%) | ||
ROIC |
(1.05%) | (1.27%) | (1.39%) | (1.41%) | |
Return on Tangible Assets |
(12.28%) | (16.84%) | (18.10%) | (14.05%) | |
Average Days of Receivables |
56.05 | 59.06 | 54.75 | 60.41 | |
Free Cash Flow per Share |
2.20 | 1.58 | 1.40 | 0.65 | |
Free Cash Flow |
1,137.00 | 815.00 | 723.00 | 332.00 | |
Capital Expenditures |
(503.00) | (504.00) | (528.00) | (513.00) | |
| Other line items | |||||
Cash ROIC |
6.67% | 4.58% | 4.13% | 1.89% | |
Accounts Receivable Turnover |
6.52 | 6.32 | 6.77 | 6.35 | |
Accounts Payable Turnover |
8.21 | 7.91 | 7.72 | 8.00 | |
Inventory Turnover |
3.41 | 3.45 | 3.53 | 3.68 | |
Average Days of Payables |
46.05 | 47.06 | 50.11 | 46.36 | |
Days of Inventory on Hand |
103.42 | 102.81 | 106.86 | 103.58 | |
Tax Rate |
2.31 | 1.00 | 0.93 | 0.78 | |
Research and Development Expense of Revenue |
4.47% | 4.46% | 4.57% | 4.61% | |
Selling, General and Administrative Expense of Revenue |
25.44% | 25.56% | 25.75% | 25.70% | |
Share Based Compensation of Revenue |
0.95% | 1.00% | 1.03% | 1.04% | |
Interest Coverage |
(0.89) | (1.11) | (1.25) | (1.29) | |
Operating CF/Net income |
(2.27) | (1.24) | (1.14) | (0.88) | |
Depreciation/Fixed assets |
0.60 | 0.59 | 0.60 | 0.60 | |
Capex/Depreciation |
(0.29) | (0.29) | (0.30) | (0.29) | |
Revenue per Share |
22.46 | 22.19 | 21.98 | 21.92 | |
Operating CF per Share |
3.17 | 2.55 | 2.43 | 1.65 | |
Capex per Share |
(0.97) | (0.97) | (1.03) | (1.00) | |
Capex to Sales |
0.04 | 0.04 | 0.05 | 0.05 |
Columns are period end dates · fundamentals updated 2 Nov 2026